cagrisema cagrilintide semaglutide phase 3 results 2024 2025 Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes cagrilintide semaglutide cagrisema phase 3

Less common but more serious side effects of GLP-1 agonists include: pancreatitis, an inflammation of the pancreas that causes abdominal pain gastroparesis, in which movement of food out of the stomach is slowed or stopped bowel obstruction, a blockage that keeps food from passing through the intestines gallstone attacks and bile duct blockage

doi:10.2147/DMSO.S312527 16

Fifth, the biggest risks at home are not the needles but hygiene shortcuts and impatience with actives, and both of those are entirely within your control

NICE recommends regular review of all diabetes medications to ensure they remain appropriate and effective, so discussing your treatment plan is an important part of ongoing diabetes care

Sticking to the recommended schedule is key to achieving and maintaining appetite suppression and weight loss results